Publication | Open Access

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line

Cell-based Drug DeliveryNanomedicineLipid PreparationGefitinib Lymphatic DeliveryEngineeringMedicineA549 Cell LinePharmaceutical NanotechnologyNano-drug DeliveryBiomedical EngineeringPharmacologyCell EngineeringNanoscale Lipid-based Formulation